Whether such a mechanism occurs within DC in the TME is currently unknown, but the authors of this study did find that silencing CTLA‐4 in bone marrow‐derived DC (BMDC) prior to electroporation with B16 melanoma mRNA improved the antitumor efficacy of BMDC vaccination against established tumors. This evidence concerns the gene CTLA4 and melanoma.